Role of tissue kallikrein in the cardioprotective effects of ischemic and pharmacological preconditioning in myocardial ischemia

FASEB Journal

Volumn 19, Issue 9, 2005, Pages 1172-1174

  Griol Charhbili, V ^a,b   Messadi Laribi, E ^a,b   Bascands, J L ^a   Heudes, D ^a   Meneton, P ^a   Giudicelli, J F ^b   Alhenc Gelas, F ^a   Richer, C ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; KALLIKREIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; RAMIPRIL; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; RNA, MESSENGER; TISSUE KALLIKREINS;

ANIMALIA;

EID: 21744457576     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.04-3508fje     Document Type: Article

References (0)